The New Cholesterol and Blood Pressure Guidelines: Perspective on the Path Forward

• Harlan M. Krumholz ^[1]
  1. [1] Robert Wood Johnson Foundation Clinical Scholars Program, Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine, Department of Health Policy and Management, Yale School of Public Health, and Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, Connecticut
• Localización: JAMA: the journal of the American Medical Association, ISSN 0098-7484, Vol. 311, Nº. 14, 2014, págs. 1403-1405
• Idioma: inglés
• Enlaces
  • Texto Completo Ejemplar
• Resumen

  • After much delay, deliberation, and drama, the long-awaited updates of the cholesterol and blood pressure guidelines were released during the last 6 months.1,2 These guidelines were intended to distill the wisdom that emerged since the last versions of these authoritative documents were released more than a decade ago. In 2008, the National Institutes of Health (NIH) appointed some of the nation’s top experts to these respective committees and provided guidance throughout almost the entirety of their 5-year development. These documents were designed to provide instructions to the nation and the world about how to manage these common risk factors for cardiovascular disease. The decision by the NIH not to oversee the final release of the documents only intensified the interest in them.